XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance, beginning (in shares) at Dec. 31, 2023   61 44,677          
Balance, beginning at Dec. 31, 2023 $ 69,739   $ 4 $ 409,343 $ (793) $ (67) $ (339,541) $ 793
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1,124     1,124        
Issuance of common stock upon exercise of stock options (in shares)     33          
Issuance of common stock upon exercise of stock options 107     107        
Other comprehensive loss (65)         (65)    
Net loss (10,011)           (10,011)  
Balance, ending (in shares) at Mar. 31, 2024   61 44,710          
Balance, ending at Mar. 31, 2024 $ 60,894   $ 4 409,781   (132) (348,759)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible Enumeration] us-gaap:AccountingStandardsUpdate202006Member              
Balance, beginning (in shares) at Dec. 31, 2024   61 66,524          
Balance, beginning at Dec. 31, 2024 $ 82,949   $ 7 467,087   34 (384,179)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1,365     1,365        
Issuance of common stock upon exercise of stock options (in shares)     2          
Issuance of common stock upon exercise of stock options 3     3        
Other comprehensive loss (7)         (7)    
Net loss (13,434)           (13,434)  
Balance, ending (in shares) at Mar. 31, 2025   61 66,526          
Balance, ending at Mar. 31, 2025 $ 70,876   $ 7 $ 468,455   $ 27 $ (397,613)